U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103057) titled 'VIZ ACCESS HCM - Multi-Site Registry' on May 13.
Brief Summary: To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
Study Start Date: June 13
Study Type: OBSERVATIONAL
Condition:
Hypertrophic Cardiomyopathy
Intervention:
DEVICE: Viz HCM
Viz HCM is a Software as a Medical Device (SaMD) intended to receive 12-lead ECG recordings co...